Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) shares fell 3.8% during trading on Wednesday . The company traded as low as $0.45 and last traded at $0.45. 214 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 1,835 shares. The stock had previously closed at $0.47.
Zelira Therapeutics Stock Performance
The company has a 50 day moving average of $0.49 and a 200 day moving average of $0.43.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Read More
- Five stocks we like better than Zelira Therapeutics
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Tesla Investors Continue to Profit From the Trump Trade
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What is the Nikkei 225 index?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
